Phase II Parallel Arm Study of Sacituzumab Govitecan-Hziy in Patients With Advanced Thymoma or Thymic Carcinoma.
Saved in:
| Title: | Phase II Parallel Arm Study of Sacituzumab Govitecan-Hziy in Patients With Advanced Thymoma or Thymic Carcinoma. |
|---|---|
| Authors: | Marks JA; Dana-Farber Cancer Institute, Boston, MA., Ahn J; Georgetown University, Washington, DC., Reuss JE; Georgetown University, Washington, DC., Barbie D; Dana-Farber Cancer Institute, Boston, MA., Altan M; The University of Texas MD Anderson Cancer Center, Houston, TX., Gutierrez ME; Hackensack University Medical Center, Hackensack, NJ., Garassino MC; University of Chicago, Chicago, IL., Riely GJ; Memorial Sloan Kettering Cancer Center, New York, NY., Wakelee H; Stanford University, Stanford, CA., Liu SV; Georgetown University, Washington, DC., Kim C; Georgetown University, Washington, DC. Electronic address: chul.kim@gunet.georgetown.edu. |
| Source: | Clinical lung cancer [Clin Lung Cancer] 2025 May; Vol. 26 (3), pp. 165-167. Date of Electronic Publication: 2024 Dec 04. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Multicenter Study |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
